These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 11431189)

  • 1. A crossover study of gabapentin in treatment of restless legs syndrome among hemodialysis patients.
    Thorp ML; Morris CD; Bagby SP
    Am J Kidney Dis; 2001 Jul; 38(1):104-8. PubMed ID: 11431189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of restless legs syndrome with gabapentin.
    Adler CH
    Clin Neuropharmacol; 1997 Apr; 20(2):148-51. PubMed ID: 9099467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gabapentin versus levodopa for the treatment of Restless Legs Syndrome in hemodialysis patients: an open-label study.
    Micozkadioglu H; Ozdemir FN; Kut A; Sezer S; Saatci U; Haberal M
    Ren Fail; 2004 Jul; 26(4):393-7. PubMed ID: 15462107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study.
    Garcia-Borreguero D; Larrosa O; de la Llave Y; Verger K; Masramon X; Hernandez G
    Neurology; 2002 Nov; 59(10):1573-9. PubMed ID: 12451200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of vitamins C, E, and their combination for treatment of restless legs syndrome in hemodialysis patients: a randomized, double-blind, placebo-controlled trial.
    Sagheb MM; Dormanesh B; Fallahzadeh MK; Akbari H; Sohrabi Nazari S; Heydari ST; Behzadi S
    Sleep Med; 2012 May; 13(5):542-5. PubMed ID: 22317944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gabapentin versus levodopa-c for the treatment of restless legs syndrome in hemodialysis patients: a randomized clinical trial.
    Razazian N; Azimi H; Heidarnejadian J; Afshari D; Ghadami MR
    Saudi J Kidney Dis Transpl; 2015 Mar; 26(2):271-8. PubMed ID: 25758874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restless legs syndrome: pathophysiology and modern management.
    Nagandla K; De S
    Postgrad Med J; 2013 Jul; 89(1053):402-10. PubMed ID: 23524988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of idiopathic restless legs syndrome (RLS) with gabapentin.
    Happe S; Klösch G; Saletu B; Zeitlhofer J
    Neurology; 2001 Nov; 57(9):1717-9. PubMed ID: 11706121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized polysomnography study of gabapentin enacarbil in subjects with restless legs syndrome.
    Winkelman JW; Bogan RK; Schmidt MH; Hudson JD; DeRossett SE; Hill-Zabala CE
    Mov Disord; 2011 Sep; 26(11):2065-72. PubMed ID: 21611981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gabapentin versus ropinirole in the treatment of idiopathic restless legs syndrome.
    Happe S; Sauter C; Klösch G; Saletu B; Zeitlhofer J
    Neuropsychobiology; 2003; 48(2):82-6. PubMed ID: 14504416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double-blind, placebo-controlled, dose-response study to assess the pharmacokinetics, efficacy, and safety of gabapentin enacarbil in subjects with restless legs syndrome.
    Lal R; Ellenbogen A; Chen D; Zomorodi K; Atluri H; Luo W; Tovera J; Hurt J; Bonzo D; Lassauzet ML; Vu A; Cundy KC
    Clin Neuropharmacol; 2012; 35(4):165-73. PubMed ID: 22664749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, double-blind, placebo-controlled study of XP13512/GSK1838262 in patients with RLS.
    Kushida CA; Becker PM; Ellenbogen AL; Canafax DM; Barrett RW;
    Neurology; 2009 Feb; 72(5):439-46. PubMed ID: 19188575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of gabapentin for uremic pruritus and restless legs syndrome in conservatively managed patients with chronic kidney disease.
    Cheikh Hassan HI; Brennan F; Collett G; Josland EA; Brown MA
    J Pain Symptom Manage; 2015 Apr; 49(4):782-9. PubMed ID: 25220049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gabapentin and uremic pruritus in hemodialysis patients.
    Razeghi E; Eskandari D; Ganji MR; Meysamie AP; Togha M; Khashayar P
    Ren Fail; 2009; 31(2):85-90. PubMed ID: 19212903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticonvulsants to treat idiopathic restless legs syndrome: systematic review.
    Conti CF; Oliveira MM; Valbuza JS; Prado LB; Carvalho LB; Prado GF
    Arq Neuropsiquiatr; 2008 Jun; 66(2B):431-5. PubMed ID: 18641891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of restless legs syndrome with gabapentin (Neurontin).
    Mellick GA; Mellick LB
    Sleep; 1996 Apr; 19(3):224-6. PubMed ID: 8723380
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study.
    Burchell BJ
    Neurology; 2003 May; 60(9):1558; author reply 1558. PubMed ID: 12743261
    [No Abstract]   [Full Text] [Related]  

  • 18. Restless legs syndrome: clinical experience with long-term treatment.
    Clavadetscher SC; Gugger M; Bassetti CL
    Sleep Med; 2004 Sep; 5(5):495-500. PubMed ID: 15341896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gabapentin enacarbil for the treatment of restless legs syndrome (RLS).
    Burke RA; Faulkner MA
    Expert Opin Pharmacother; 2011 Dec; 12(18):2905-14. PubMed ID: 22077768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gabapentin enacarbil for treatment of restless legs syndrome in adults.
    Hayes WJ; Lemon MD; Farver DK
    Ann Pharmacother; 2012 Feb; 46(2):229-39. PubMed ID: 22298601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.